Table 2.
Univariate analysis for the effect of lymph node ratio (LNR) influencing overall and disease-free survival
| LNR | No. of patients | 5-year OS | p | 5-year DFS | P |
|---|---|---|---|---|---|
| ≤ 0.05 | 4 | 100 | 0.282 | 75.0 | 0.441 |
| > 0.05 | 35 | 63.9 | 48.8 | ||
| ≤ 0.1 | 16 | 93.3 | 0.037 | 72.7 | 0.026 |
| > 0.1 | 23 | 52.6 | 36.9 | ||
| ≤ 0.15 | 20 | 94.7 | 0.004 | 73.0 | 0.002 |
| > 0.15 | 19 | 42.9 | 30.7 | ||
| ≤ 0.2 | 24 | 85.9 | 0.040 | 67.8 | 0.002 |
| > 0.2 | 15 | 47.4 | 25.0 | ||
| ≤ 0.25 | 28 | 84.1 | 0.014 | 61.6 | 0.014 |
| > 0.25 | 11 | 36.8 | 24.2 | ||
| ≤ 0.3 | 32 | 79.3 | 0.047 | 53.6 | 0.419 |
| > 0.3 | 7 | 35.7 | 42.9 |
LNR: Lymph Node Ratio; OS: Overall Survival; DFS: Disease-Free Survival.